Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

KalVista Pharmaceuticals (KALV) FCF Margin: 2014-2020

Historic FCF Margin for KalVista Pharmaceuticals (KALV) over the last 6 years, with Apr 2020 value amounting to -330.18%.

  • KalVista Pharmaceuticals' FCF Margin rose 3845.00% to -330.18% in Q2 2020 from the same period last year, while for Apr 2020 it was -354.89%, marking a year-over-year decrease of 12268.00%. This contributed to the annual value of 2,651.72% for FY2025, which is 283098.00% up from last year.
  • Per KalVista Pharmaceuticals' latest filing, its FCF Margin stood at -330.18% for Q2 2020, which was up 60.28% from -831.26% recorded in Q1 2020.
  • In the past 5 years, KalVista Pharmaceuticals' FCF Margin ranged from a high of 1,202.83% in Q1 2018 and a low of -75,257.14% during Q1 2016.
  • Over the past 3 years, KalVista Pharmaceuticals' median FCF Margin value was -240.92% (recorded in 2019), while the average stood at -163.54%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by 1,484,286bps in 2016, then surged by 573,791bps in 2018.
  • KalVista Pharmaceuticals' FCF Margin (Quarterly) stood at -2,134.01% in 2016, then soared by 148,539bps to -648.62% in 2017, then surged by 48,756bps to -161.07% in 2018, then slumped by 4,118bps to -202.24% in 2019, then surged by 3,845bps to -330.18% in 2020.
  • Its FCF Margin stands at -330.18% for Q2 2020, versus -831.26% for Q1 2020 and -202.24% for Q4 2019.